Can Cannabis Help Prevent Diabetes? New Study Shows Potential Benefits

New research indicates that cannabis users may have healthier body responses to inflammation and better control of blood sugar levels, potentially reducing the risk of diabetes. The study, conducted as part of the SONIC trial, examined the health profiles of regular cannabis users.

The research found that these individuals often had healthier inflammatory responses and superior blood sugar regulation compared to non-users. Angela Bryan, Ph.D., co-director of CUChange at the University of Colorado, Boulder, remarked, “Those inflammatory profiles would improve over the course of 4 weeks, particularly for those using a CBD [cannabidiol] as opposed to a THC [tetrahydrocannabinol] product.”

Research Findings

Participants in the study, who were generally young and physically active, were compared to non-users of similar demographics. The study included oral glucose tolerance tests and various assessments of inflammatory markers to measure insulin sensitivity. Over four weeks, participants documented their cannabis use, diet, and physical activity. While no significant changes in inflammatory markers were observed during the study period, cannabis users had lower levels of certain inflammatory biomarkers and cytokines than non-users. An exception was found in the levels of monocyte chemoattractant protein 1 (MCP-1), a protein involved in the immune response.

What Does This Mean?

This research aligns with previous studies showing that cannabinoids and cannabis terpenes can effectively reduce pain and inflammation. Such findings have contributed to the growing acceptance of cannabis among athletes and those suffering from chronic pain. Bryan’s research also explores how cannabis use before exercise might enhance the enjoyment of physical activity, potentially making it more appealing to those at risk for diabetes. Another study suggested that CBD-dominant cannabis could reduce acute tension and long-term anxiety, relevant for managing diabetes-related stress.

Where To Learn More

These findings on cannabis and diabetes prevention will be a topic of conversation at Benzinga’s Cannabis Capital Conference, which will be held October 8-9 at the Marriott Magnificent Mile in Chicago. The event will gather industry leaders, political figures, and market decision-makers to discuss the future of cannabis investment and branding. The previous conference in Hollywood, FL, attracted over 2,000 participants, including more than 200 investors, highlighting the event’s importance in the cannabis industry.

In summary, the new study on cannabis use and diabetes prevention adds to the growing body of evidence supporting the health benefits of cannabis. These findings, alongside discussions at the upcoming Benzinga Cannabis Capital Conference, will likely influence future research directions and investment opportunities in the cannabis industry.

Image: Bukhta Yurii via Shutterstock